FDA Stricter With Antibody Remedy Than Earlier Trump-Touted Drug

Published October 13, 2020

An FDA authorization of an experimental antibody treatment administered to President Donald Trump will likely have to clear a higher bar than the one used for the now-withdrawn hydroxychlorquine, the agency’s longtime drug chief said.